Parallel Advisors, LLC Uro Gen Pharma Ltd. Transaction History

Parallel Advisors, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$5.12 - $8.74 $15,600 - $26,630	-3,047 Closed	0 $0
Q1 2022 Apr 28, 2022	BUY	$5.92 - $9.73 $17,760 - $29,190	3,000 Added 6382.98%	3,047 $28,000
Q2 2021 Aug 06, 2021	SELL	$15.2 - $20.94 $30,400 - $41,880	-2,000 Reduced 97.7%	47 $1,000
Q1 2021 Apr 23, 2021	BUY	$17.99 - $26.96 $16,982 - $25,450	944 Added 85.58%	2,047 $40,000
Q4 2020 Feb 02, 2021	SELL	$17.54 - $25.43 $25,327 - $36,720	-1,444 Reduced 56.69%	1,103 $20,000

Q3 2020 Oct 27, 2020	BUY	$18.81 - $26.42 $28,214 - $39,630	1,500 Added 143.27%	2,547 $49,000
Q2 2020 Jul 16, 2020	BUY	$16.5 - $29.7 $17,275 - $31,095	1,047 New	1,047 $27,000
Q1 2020 Apr 27, 2020	SELL	$13.68 - $34.6 $36,936 - $93,420	-2,700 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$21.11 - $34.86 $25,332 - $41,832	1,200 Added 80.0%	2,700 $90,000
Q3 2019 Nov 01, 2019	BUY	$23.83 - $36.44 $35,745 - $54,660	1,500 New	1,500 $36,000
Q2 2019 Aug 05, 2019	SELL	$32.75 - $40.35 $32,750 - $40,350	-1,000 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$38.35 - $50.39 $19,175 - $25,195	500 Added 100.0%	1,000 $43,000
Q3 2018 Nov 01, 2018	SELL	$41.65 - $51.7 $62,475 - $77,550	-1,500 Reduced 75.0%	500 $24,000
Q2 2018 Jul 30, 2018	BUY	$48.35 - $65.33 $53,185 - $71,863	1,100 Added 122.22%	2,000 $99,000
Q1 2018 May 08, 2018	BUY	$38.64 - $57.54 $3,864 - $5,754	100 Added 12.5%	900 $45,000
Q3 2017 Nov 15, 2017	BUY	$17.15 - $32.72 $13,719 - $26,176	800	800 $35,000

113

24M

46.9K

44.3K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $373M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.